Ovarian Cancer GOG 9928
March 13, 2013
Location: The Hospital of Central Connecticut
A Phase I Study Of Intraperitoneal Egen-001 Administered In Combination With Pegylated Liposomal Doxorubicin In Patients With Recurrent Or Persistent Epithelial Ovarian, Fallopian Tube Or Primary Peritoneal Cancer.